IL5 and chronic rhinosinusitis with nasal polyps: CRSwNP patients that responded to FESS were determined to have a statistically significantly higher median level of nasal IL-5 compared to non-responders (63 pg/μL [28, 118] versus 17 pg/μL [16.6, 18], p = 0.04).